There’s been much recent gnashing of teeth (at least within the narrow and rather insular world of do-it-yourself genomics) about the gall of the FDA in choosing to issue a warning letter to 23andMe, effectively shutting down marketing of their direct-to-consumer personal genomic profiling. And adding to 23andMe’s woes, a class action suit has been […]
A grand jury in Travis County, Texas, indicted a former official of the Cancer Prevention and Research Institute of Texas for bypassing peer review in awarding an $11 million grant to a Dallas-based company. Jerald Cobbs, the former CPRIT chief commercialization officer, was indicted on a felony charge of deceiving two of his CPRIT colleagues […]
Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles with SEC Over Shorting Dendreon Stock An Earmark in the Making: NCI Urged to Boost Gastric Cancer Funding Johnson to Leave NCI Office of Communications FDA Expands Nexavar Indication to Include Thyroid Cancer
A group of members of both chambers of Congress is urging NCI to increase funding for research in gastric cancers—the latest in a string of advocacy initiatives to carve out fiscal support for specific diseases. “Deadly gastric cancer is on the rise in young people,” reads a Nov. 26 letter from five members of the […]
The lead author of a paper that argued that the prostate cancer immunotherapy Provenge endangered lives of cancer patients has entered a settlement agreement with the Securities and Exchange Commission. The agreement states that Marie Huber, an analyst at a hedge fund, had prepared and anonymously circulated a paper about Provenge (sipuleucel-T) at a time […]
AMY ABERNETHY was named chair of a new CancerLinQ advisory committee within the Institute for Quality, an affiliate of the American Society of Clinical Oncology.
Issue 44 – Nov. 22, 2013 PDF ASCO Vying for Big Role in Big Data Conversation with The Cancer Letter: ASCO President Clifford HudisThe American Society of Clinical Oncology is in the final stages of developing a request for proposals for its CancerLinQ system. The RFP is expected to be issued early in 2014. Biospecimen […]
